Wimmer Associates 1’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.06M | Hold |
3,667
| – | – | 1.01% | 27 |
|
|
2025
Q4 | $2.48M | Sell |
3,667
-5
| -0.1% | -$3.4K | 1.15% | 23 |
|
|
2025
Q3 | $2.35M | Hold |
3,672
| – | – | 1.13% | 23 |
|
|
2025
Q2 | $1.97M | Hold |
3,672
| – | – | 1.01% | 28 |
|
|
2025
Q1 | $1.87M | Hold |
3,672
| – | – | 0.99% | 28 |
|
|
2024
Q4 | $1.52M | Hold |
3,672
| – | – | 0.75% | 32 |
|
|
2024
Q3 | $1.86M | Hold |
3,672
| – | – | 0.91% | 29 |
|
|
2024
Q2 | $1.79M | Hold |
3,672
| – | – | 0.92% | 30 |
|
|
2024
Q1 | $1.98M | Hold |
3,672
| – | – | 1.04% | 29 |
|
|
2023
Q4 | $2.04M | Sell |
3,672
-30
| -0.8% | -$14.1K | 1.15% | 29 |
|
|
2023
Q3 | $1.62M | Hold |
3,702
| – | – | 1.01% | 31 |
|
|
2023
Q2 | $1.86M | Hold |
3,702
| – | – | 1.12% | 28 |
|
|
2023
Q1 | $1.81M | Buy |
3,702
+10
| +0.3% | +$4.79K | 1.16% | 28 |
|
|
2022
Q4 | $1.51M | Buy |
3,692
+5
| +0.1% | +$1.94K | 0.99% | 30 |
|
|
2022
Q3 | $1.33M | Buy |
3,687
+15
| +0.4% | +$5.51K | 0.88% | 35 |
|
|
2022
Q2 | $1.29M | Buy |
3,672
+40
| +1% | +$16.3K | 0.84% | 37 |
|
|
2022
Q1 | $1.99M | Sell |
3,632
-130
| -3% | -$68.4K | 1.1% | 31 |
|
|
2021
Q4 | $2.48M | Hold |
3,762
| – | – | 1.33% | 24 |
|
|
2021
Q3 | $2.34M | Sell |
3,762
-8
| -0.2% | -$5.38K | 1.39% | 23 |
|
|
2021
Q2 | $2.38M | Sell |
3,770
-200
| -5% | -$110K | 1.4% | 22 |
|
|
2021
Q1 | $1.94M | Buy |
3,970
+18
| +0.5% | +$9.02K | 1.06% | 30 |
|
|
2020
Q4 | $1.98M | Sell |
3,952
-20
| -0.5% | -$8.95K | 1.18% | 25 |
|
|
2020
Q3 | $1.56M | Hold |
3,972
| – | – | 1.05% | 28 |
|
|
2020
Q2 | $1.5M | Hold |
3,972
| – | – | 1.17% | 27 |
|
|
2020
Q1 | $962K | Buy |
3,972
+800
| +25% | +$209K | 0.9% | 34 |
|
|
2019
Q4 | $828K | Buy |
3,172
+50
| +2% | +$13.2K | 0.66% | 47 |
|
|
2019
Q3 | $849K | Hold |
3,122
| – | – | 0.74% | 44 |
|
|
2019
Q2 | $860K | Hold |
3,122
| – | – | 0.75% | 44 |
|
|
2019
Q1 | $698K | Hold |
3,122
| – | – | 0.62% | 52 |
|
|
2018
Q4 | $581K | Hold |
3,122
| – | – | 0.58% | 52 |
|
|
2018
Q3 | $779K | Sell |
3,122
-479
| -13% | -$116K | 0.65% | 48 |
|
|
2018
Q2 | $785K | Hold |
3,601
| – | – | 0.7% | 48 |
|
|
2018
Q1 | $689K | Hold |
3,601
| – | – | 0.61% | 49 |
|
|
2017
Q4 | $563K | Hold |
3,601
| – | – | 0.51% | 59 |
|
|
2017
Q3 | $560K | Hold |
3,601
| – | – | 0.52% | 60 |
|
|
2017
Q2 | $581K | Sell |
3,601
-321
| -8% | -$52.1K | 0.54% | 57 |
|
|
2017
Q1 | $606K | Hold |
3,922
| – | – | 0.57% | 55 |
|
|
2016
Q4 | $460K | Buy |
3,922
+100
| +3% | +$11.4K | 0.43% | 68 |
|
|
2016
Q3 | $431K | Hold |
3,822
| – | – | 0.39% | 75 |
|
|
2016
Q2 | $355K | Buy |
3,822
+140
| +4% | +$12K | 0.32% | 85 |
|
|
2016
Q1 | $288K | Hold |
3,682
| – | – | 0.26% | 89 |
|
|
2015
Q4 | $268K | Buy |
+3,682
| New | +$263K | 0.28% | 83 |
|
Other funds holding IDXX
VCM
VPM
Wimmer Associates 1's IDXX Position: Q1 2026 in Review
Wimmer Associates 1 held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 3,667 shares worth $2.06M. The position accounts for 1.01% of the portfolio, ranked #27.
Wimmer Associates 1 first reported a position in IDXX in Q4 2015 and has held it in 42 quarters since. The position peaked at $2.48M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Wimmer Associates 1 held 3,667 shares of Idexx Laboratories worth $2.06M as of Q1 2026.
- Wimmer Associates 1 left its Idexx Laboratories share count unchanged in Q1 2026.
- Idexx Laboratories made up 1.01% of Wimmer Associates 1's portfolio in Q1 2026, its #27 holding.
- Wimmer Associates 1 first reported a position in Idexx Laboratories in Q4 2015 and has held it in 42 quarters since.
- Wimmer Associates 1's Idexx Laboratories position peaked at $2.48M in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Wimmer Associates 1's 13F filing for Q1 2026, filed 15 May 2026.